Contribution: Industrial Research Assistance Program – Contributions to Firms
Aspect Biosystems Ltd.
$401,700.00
Germany ZIM project 3D Gewebe - Production and validation of multiple 3D-printed human contractile tissues
FY 2017-18 · 2017-08-01
Summary
This international collaborative project integrates innovative Canadian bioprinting technology with unique cell immortalization and tissue technology from Germany in order to generate and validate a portfolio of highly physiological and functional living bioprinted 3D human tissues.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Vancouver|Vancouver, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
830167839
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 1 | 2017-08-01 | 2017-18 | $401,700.00 |
| 2 | 2017-08-01 | 2017-18 | $401,700.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 92 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 92 jours.
Agreement End Date
2020-10-31
Agreement Number
891779
Agreement Start Date
2017-08-01
Agreement Title
Germany ZIM project 3D Gewebe - Production and validation of multiple 3D-printed human contractile tissues
Agreement Title (French)
Production et validation de multiples tissus contractiles humains imprimés en 3D
Agreement Type
Contribution
Agreement Value
$401,700.00
Amendment Date
2020-06-16
Amendment Number
2
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This international collaborative project integrates innovative Canadian bioprinting technology with unique cell immortalization and tissue technology from Germany in order to generate and validate a portfolio of highly physiological and functional living bioprinted 3D human tissues.
Description (French)
Ce projet de collaboration internationale intègre la technologie innovatrice de la bioimpression canadienne à la technologie unique d'immortalisation cellulaire et tissulaire de l'Allemagne afin de générer et de valider un portefeuille de tissus humains 3D bioimprimés vivants, hautement physiologiques et fonctionnels.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vancouver Quadra
Federal Riding (French)
Vancouver Quadra
Federal Riding Number
59039
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
830167839
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
Aspect Biosystems Ltd.
Recipient Postal Code
V6P 6P2
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2019-2020-Q2-891779
